Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow).

PubWeight™: 3.07‹?› | Rank: Top 1%

🔗 View Article (PMID 17525288)

Published in Blood on May 24, 2007

Authors

Antonio P Beltrami1, Daniela Cesselli, Natascha Bergamin, Patrizia Marcon, Silvia Rigo, Elisa Puppato, Federica D'Aurizio, Roberto Verardo, Silvano Piazza, Angela Pignatelli, Alessandra Poz, Umberto Baccarani, Daniela Damiani, Renato Fanin, Laura Mariuzzi, Nicoletta Finato, Paola Masolini, Silvia Burelli, Ottorino Belluzzi, Claudio Schneider, Carlo A Beltrami

Author Affiliations

1: Centro Interdipartimentale Medicina Rigenerativa, University of Udine, Piazzale Santa Maria della Misericordia, 33100 Udine, Italy. beltrami@uniud.it

Articles citing this

Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell (2008) 6.26

Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell (2007) 5.29

Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med (2009) 4.03

Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell (2011) 3.49

Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol (2009) 2.37

Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res (2011) 1.78

The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues. Stem Cells Dev (2014) 1.70

Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation (2010) 1.69

Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res (2012) 1.65

Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther (2010) 1.63

Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc (2009) 1.62

Effects of age and heart failure on human cardiac stem cell function. Am J Pathol (2011) 1.57

Mesenchymal stem cells and cardiac repair. J Cell Mol Med (2008) 1.37

Very small embryonic-like stem cells: characterization, developmental origin, and biological significance. Exp Hematol (2008) 1.35

Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci (2013) 1.31

Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell. PLoS One (2012) 1.25

EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells. BMC Mol Biol (2010) 1.21

Very small embryonic-like (VSEL) stem cells in adult organs and their potential role in rejuvenation of tissues and longevity. Exp Gerontol (2008) 1.20

"Small stem cells" in adult tissues: very small embryonic-like stem cells stand up! Cytometry A (2009) 1.18

A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking. Leukemia (2014) 1.18

Epiblast/germ line hypothesis of cancer development revisited: lesson from the presence of Oct-4+ cells in adult tissues. Stem Cell Rev (2010) 1.17

MT1-MMP controls human mesenchymal stem cell trafficking and differentiation. Blood (2009) 1.17

The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells (2011) 1.12

GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration. PLoS One (2012) 1.12

Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis. PLoS One (2009) 1.12

Very small embryonic-like stem cells (VSELs) represent a real challenge in stem cell biology: recent pros and cons in the midst of a lively debate. Leukemia (2013) 1.10

Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med (2014) 1.10

Identification of a stem cell niche in the zone of Ranvier within the knee joint. J Anat (2009) 1.09

Do pluripotent stem cells exist in adult mice as very small embryonic stem cells? Stem Cell Reports (2013) 1.06

Hunt for pluripotent stem cell -- regenerative medicine search for almighty cell. J Autoimmun (2008) 1.04

Very small embryonic/epiblast-like stem cells: a missing link to support the germ line hypothesis of cancer development? Am J Pathol (2009) 1.01

Defective myofibroblast formation from mesenchymal stem cells in the aging murine heart rescue by activation of the AMPK pathway. Am J Pathol (2011) 1.00

Very small embryonic-like stem cells in adult tissues-potential implications for aging. Mech Ageing Dev (2008) 0.99

Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma. Sarcoma (2010) 0.99

Adipose tissue derived stem cells: in vitro and in vivo analysis of a standard and three commercially available cell-assisted lipotransfer techniques. Stem Cell Res Ther (2015) 0.96

Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrin alpha5beta1. PLoS One (2009) 0.95

Role of Oct4 in the early embryo development. Cell Regen (Lond) (2014) 0.94

Cord blood Lin(-)CD45(-) embryonic-like stem cells are a heterogeneous population that lack self-renewal capacity. PLoS One (2013) 0.93

Adult stem cells from the hyaluronic acid-rich node and duct system differentiate into neuronal cells and repair brain injury. Stem Cells Dev (2014) 0.93

Very small embryonic/epiblast-like stem cells (VSELs) and their potential role in aging and organ rejuvenation--an update and comparison to other primitive small stem cells isolated from adult tissues. Aging (Albany NY) (2012) 0.92

Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent. Microvasc Res (2011) 0.92

Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng Part B Rev (2012) 0.91

Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology? Transfus Med Hemother (2010) 0.91

Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure. Am J Pathol (2011) 0.90

Genome-wide analysis of murine bone marrow‑derived very small embryonic-like stem cells reveals that mitogenic growth factor signaling pathways play a crucial role in the quiescence and ageing of these cells. Int J Mol Med (2013) 0.89

Dental pulp stem cells differentiation reveals new insights in Oct4A dynamics. PLoS One (2012) 0.89

A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient's skin. Orphanet J Rare Dis (2013) 0.88

Endometrial stem cells in regenerative medicine. J Biol Eng (2014) 0.88

Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. Int J Hepatol (2011) 0.86

Expression of the erythropoietin receptor by germline-derived cells - further support for a potential developmental link between the germline and hematopoiesis. J Ovarian Res (2014) 0.86

Comparison of phenotypic markers and neural differentiation potential of multipotent adult progenitor cells and mesenchymal stem cells. World J Stem Cells (2013) 0.86

Bone Marrow - Home of Versatile Stem Cells. Transfus Med Hemother (2008) 0.85

Positive effects of prolonged caloric restriction on the population of very small embryonic-like stem cells - hematopoietic and ovarian implications. J Ovarian Res (2014) 0.84

Expression of stem cell markers in primo vessel of rat. Evid Based Complement Alternat Med (2013) 0.84

Very small embryonic-like stem-cell optimization of isolation protocols: an update of molecular signatures and a review of current in vivo applications. Exp Mol Med (2013) 0.83

Links between growth hormone and aging. Endokrynol Pol (2013) 0.82

Optimization of the isolation and expansion method of human mediastinal-adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate. Cytotechnology (2013) 0.82

Very small embryonic-like stem cells: biology and therapeutic potential for heart repair. Antioxid Redox Signal (2011) 0.82

The redox function of APE1 is involved in the differentiation process of stem cells toward a neuronal cell fate. PLoS One (2014) 0.81

Bone transplantation and tissue engineering, part IV. Mesenchymal stem cells: history in orthopedic surgery from Cohnheim and Goujon to the Nobel Prize of Yamanaka. Int Orthop (2015) 0.81

In vivo tracking of murine adipose tissue-derived multipotent adult stem cells and ex vivo cross-validation. Int J Mol Imaging (2013) 0.81

Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells. Stem Cell Res Ther (2016) 0.80

The potential of stem cells in the treatment of cardiovascular diseases. Stem Cell Rev (2013) 0.80

The molecular nature of very small embryonic-like stem cells in adult tissues. Int J Stem Cells (2014) 0.80

Interfacing Sca-1(pos) mesenchymal stem cells with biocompatible scaffolds with different chemical composition and geometry. J Biomed Biotechnol (2009) 0.80

Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and Brain. Int J Mol Sci (2015) 0.80

Aging of the inceptive cellular population: the relationship between stem cells and aging. Aging (Albany NY) (2009) 0.79

Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease. J Am Heart Assoc (2015) 0.79

Differentiation of rat multipotent adult progenitor cells to functional hepatocyte-like cells by mimicking embryonic liver development. Nat Protoc (2010) 0.78

A porous membrane-mediated isolation of mesenchymal stem cells from human embryonic stem cells. Tissue Eng Part C Methods (2014) 0.78

Application of a novel population of multipotent stem cells derived from skin fibroblasts as donor cells in bovine SCNT. PLoS One (2015) 0.77

Long-term survival of exogenous embryonic stem cells in adult bone marrow. Cell Res (2011) 0.77

Dormancy activation mechanism of tracheal stem cells. Oncotarget (2016) 0.77

A Novel View of the Adult Stem Cell Compartment From the Perspective of a Quiescent Population of Very Small Embryonic-Like Stem Cells. Circ Res (2017) 0.77

Encapsulated stem cells for cancer therapy. Biomatter (2013) 0.77

Quo Vadis medycyno regeneracyjna?: Quo Vadis Regenerative Medicine? Acta Haematol Pol (2013) 0.76

Ultrasensitive nanostructured immunosensor for stem and carcinoma cell pluripotency gatekeeper protein NANOG. Nanomedicine (Lond) (2012) 0.76

Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke. Philos Trans R Soc Lond B Biol Sci (2015) 0.75

Management of Liver Failure: From Transplantation to Cell-Based Therapy. Cell Med (2011) 0.75

Genesis of myocardial repair with cardiac progenitor cells and tissue engineering. Heart Asia (2010) 0.75

Tissue-Specific Cultured Human Pericytes: Perivascular Cells from Smooth Muscle Tissue Have Restricted Mesodermal Differentiation Ability. Stem Cells Dev (2016) 0.75

Identification of New Rat Bone Marrow-Derived Population of Very Small Stem Cell with Oct-4A and Nanog Expression by Flow Cytometric Platforms. Stem Cells Int (2015) 0.75

SOX2, OCT3/4 and NANOG expression and cellular plasticity in rare human somatic cells requires CD73. Cell Signal (2016) 0.75

Functional expression of aryl hydrocarbon receptor on mast cells populating human endometriotic tissues. Lab Invest (2016) 0.75

Expression of OCT-4 and SOX-2 in Bone Marrow-Derived Human Mesenchymal Stem Cells during Osteogenic Differentiation. Open Access Maced J Med Sci (2016) 0.75

Life is plastic. Blood (2008) 0.75

Involvement of PI3K and MMP1 in PDGF-induced Migration of Human Adipose-derived Stem Cells. Balsaenggwa Saengsig (2017) 0.75

Stem cells and their potential clinical applications in psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry (2017) 0.75

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Chimerism of the transplanted heart. N Engl J Med (2002) 8.69

A promoter-level mammalian expression atlas. Nature (2014) 6.25

A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med (2007) 4.59

Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. N Engl J Med (1994) 3.26

Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet (2003) 3.15

The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature (2002) 3.02

Myocyte turnover in the aging human heart. Circ Res (2010) 2.77

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood (2011) 2.74

Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood (2003) 2.02

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Haematologica (2008) 1.97

A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell (2011) 1.95

p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol (2009) 1.83

MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci U S A (2006) 1.82

Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res (2011) 1.78

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma. Blood (2011) 1.76

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis. Rheumatology (Oxford) (2009) 1.76

Calpain is required for macroautophagy in mammalian cells. J Cell Biol (2006) 1.75

Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases. Leuk Lymphoma (2003) 1.74

Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci U S A (2007) 1.74

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood (2009) 1.74

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica (2002) 1.72

Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation (2010) 1.69

Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol (2005) 1.69

Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci U S A (2009) 1.64

WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood (2008) 1.63

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica (2007) 1.59

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. Blood (2012) 1.59

Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int (2009) 1.58

Effects of age and heart failure on human cardiac stem cell function. Am J Pathol (2011) 1.57

Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. J Biol Chem (2003) 1.57

Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol Cell (2004) 1.55

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54

Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol Biol Cell (2004) 1.51

Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL). Blood (2006) 1.49

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells. Arthritis Rheum (2002) 1.48

B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica (2003) 1.48

The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. Exp Hematol (2006) 1.46

Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. Br J Haematol (2005) 1.45

Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience. Ann Surg (2006) 1.43

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem (2003) 1.41

Which type of incision for liver transplantation? Liver Transpl (2009) 1.40

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo. Blood (2008) 1.40

Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40

Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays. Clin Chem Lab Med (2013) 1.39

Caspase-2 can trigger cytochrome C release and apoptosis from the nucleus. J Biol Chem (2002) 1.39

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood (2010) 1.34

The PDZ protein tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells. J Biol Chem (2003) 1.32

Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica (2006) 1.32

HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness. Oncotarget (2013) 1.29

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica (2009) 1.28

Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev (2008) 1.24

Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis. Blood (2003) 1.23

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle (2013) 1.23

Multipotent progenitor cells are present in human peripheral blood. Circ Res (2009) 1.20

Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction. Neuron (2007) 1.19

miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response. Cancer Res (2010) 1.19

Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res (2011) 1.18

hGTSE-1 expression stimulates cytoplasmic localization of p53. J Biol Chem (2004) 1.18

The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function. J Biol Chem (2003) 1.18

Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2. Oncogene (2004) 1.16

The transcriptional repressor hDaxx potentiates p53-dependent apoptosis. J Biol Chem (2004) 1.16

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Haematologica (2008) 1.16

GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration. PLoS One (2012) 1.12

Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient. Clin Infect Dis (2006) 1.09

Combined approach for spontaneous rupture of hepatocellular carcinoma. World J Hepatol (2010) 1.08

Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages. Clin Pharmacokinet (2004) 1.07

Robot-assisted renal transplantation compared with conventional surgery: a real benefit? Transpl Int (2014) 1.07

The calpain system as a modulator of stress/damage response. Cell Cycle (2007) 1.07